Seth Lederman
Overview
Seth Lederman received an average of $2M in total compensation, including $455K in salary, at Tonix Pharmaceuticals Holding from 2012 to 2023.
2023Tonix Pharmaceuticals HoldingChief Executive Officer
2022Tonix Pharmaceuticals HoldingChief Executive Officer
2021Tonix Pharmaceuticals HoldingChief Executive Officer
2020Tonix Pharmaceuticals HoldingChief Executive Officer
2019Tonix Pharmaceuticals HoldingChief Executive Officer
2018Tonix Pharmaceuticals HoldingChief Executive Officer
2017Tonix Pharmaceuticals HoldingChief Executive Officer
2016Tonix Pharmaceuticals HoldingChief Executive Officer
2015Tonix Pharmaceuticals HoldingChief Executive Officer
2014Tonix Pharmaceuticals HoldingChief Executive Officer
Source: SEC filings on April 15, 2024, March 17, 2023, March 18, 2022, March 31, 2021, March 30, 2020, December 13, 2019, April 19, 2018, May 2, 2017, March 25, 2016, and May 2, 2014.
Related executives
We found five more executives who work or worked at Tonix Pharmaceuticals Holding.
Gregory Sullivan
Tonix Pharmaceuticals Holding
Chief Medical Officer
Jessica Morris
Tonix Pharmaceuticals Holding
Chief Operations Officer
Bradley Saenger
Tonix Pharmaceuticals Holding
Chief Financial Officer
Leland Gershell
Tonix Pharmaceuticals Holding
Chief Financial Officer
Bruce Daugherty
Tonix Pharmaceuticals Holding
Chief Scientific Officer
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019